1142-181 Does indexation to fat-free mass eliminate or reverse gender differences in left ventricular mass?  by Chuang, Michael L et al.
512A ABSTRACTS - Vascular Disease, Hypertension, and Prevention JACC  March 3, 2004
Va
sc
ul
ar
 D
is
ea
se
, H
yp
er
te
ns
io
n,
 a
nd
 P
re
ve
nt
io
n
1142-179 Body Fat Distribution Influences Cardiac Output in 
Normotensive and Hypertensive Overweight 
Individuals: The HyperGEN Study
Giovanni de Simone, Richard B. Devereux, Marcello Chinali, Vittorio Palmieri, Albert 
Oberman, Dalane W. Kitzman, Paul N. Hopkins, D. C. Rao, Donna K. Arnett, Weill 
Medical College, New York, NY, Federico II University, Napoli, Italy
Background: We have shown that in obesity increased cardiac output is related to fat-
free mass but also to adipose mass. Whether these relations are present in milder over-
weight and similar with central (CFD) or peripheral fat distribution (PFD) has never been
explored in population studies. Method: 522 overweight, non-obese participants (NIH
1998) in the HyperGEN study, without diabetes or known cardiovascular disease, and
with normal LV function were studied (262 with CFD, by waist girth>88/102 cm in women/
men). Fat-free and adipose mass were measured by bioelectric impedance and body
composition was estimated as the ratio of adipose to fat-free mass (A/FFMr). Stroke vol-
ume (SV) and cardiac output (CO) were measured by echocardiography. Results:
Hypertension was present in 73% of PFD and 78% of CFD. Table shows that overweight
with CFD was associated with greater adiposity, similar in normotensive and hyperten-
sive participants. At comparable fat-free mass, CO was higher in overweight with CFD
than in PFD, whereas peripheral resistance was similar. CO was related to adipose mass
(beta=0.13, p<0.01), independently of fat-free mass (beta=0.30, both p<0.0001) and Afri-
can-American ethnicity (beta=0.10, p<0.03); no independent relations were found with
age, sex or hypertension. Conclusions: in overweight, non obese subjects, central fat
distribution is associated with more severe degree of abnormalities in body composition
and influences magnitude of cardiac output independently of fat-free mass.
1142-180 Peroxisome Proliferator-Activated Receptor-Alpha 
Intron 7 Polymorphism Exhibits Racial Dimorphism and 
Is Associated With Increased Left Ventricular Mass
Lisa de las Fuentes, Sheng-Jing Dong, Alan D. Waggoner, Sharon Cresci, Sharon 
Marsh, Howard L. McLeod, Daniel P. Kelly, Victor G. Davila-Roman, Washington 
University, Saint Louis, MO
Background: Peroxisome proliferator-activated receptor-alpha (PPARα) is a key tran-
scription regulator of myocardial fatty acid metabolism. Recently an intron 7 G>C poly-
morphism in the PPARα gene was associated with pathologic left ventricular (LV)
hypertrophy in Caucasian men, but not in women. The frequency of the polymorphism
and its influence on measures of myocardial LV mass (LVM) has not been well evaluated
in a racially mixed population.
Methods and Results: The PPARα intron 7 G>C polymorphism was genotyped in 107
subjects to investigate a relationship with LVM. There was no significant difference in sys-
tolic BP, LV ejection fraction (LVEF) or history of HTN between the 4 groups, or within the
groups between genotypes. The allelic frequencies were racially dimorphic [C allele fre-
quency =0.22 in Non-African Americans (NAA) and 0.52 in African Americans (AA)].
Among NAA women, the intron 7 CC genotype was significantly associated with
increased LVM (LVM/Ht2.7, p<0.001 vs. GG and GC); a similar association was found
among NAA men (p=0.048 GG vs. CC). No association of intron 7 genotypes and LVM
were found among AA women or men, albiet this subgroup had a smaller sample size.
Conclusions: 1) The PPARα intron 7 G>C polymorphism is racially dimorphic and 2)
this study confirms the influence of the PPARα intron 7 CC genotype on LVH in NAA
men, and extends this to NAA women. Given the racial dimorphism in allelic frequencies
further investigation is warranted to evaluate whether the C allele is associated with LVM
in AA.
1142-181 Does Indexation to Fat-Free Mass Eliminate or Reverse 
Gender Differences in Left Ventricular Mass?
Michael L. Chuang, Carol J. Salton, Kraig V. Kissinger, Christopher J. O'Donnell, Daniel 
Levy, Warren J. Manning, Beth Israel Deaconess Medical Center, Boston, MA, NHLBI's 
Framingham Heart Study, Framingham, MA
Mean left ventricular mass (LVM) is greater in men than women, regardless of indexation
to height (Ht) or body surface area (BSA). Indexation to fat-free body mass (FFM) may
better reflect metabolic demand, potentially allowing improved identification of inappropri-
ately elevated LVM, but the gender-differential effect of indexation to FFM on LVM by car-
diovascular magnetic resonance (CMR) is unknown.
Methods: Clinically healthy adults (144 women and 135 men, aged 59±9 years) from the
Framingham Offspring cohort underwent volumetric FFE-EPI CMR (1.5T, Philips) to
determine LVM. FFM was determined using two gender-specific methods: Kvist formula
FFM=Wt-(0.923*(1.36*Wt/Ht-42.0)), men, FFM=Wt-(0.923*(1.61*Wt/Ht-38.3)), women,
Wt=weight. Kuch FFM= 5.1*Ht^1.14*Wt^0.41, men; FFM=5.34*Ht^1.47*Wt^0.33,
women. LVM was indexed to Ht, Wt, BSA, Ht^2.7 and Kvist and Kuch FFM. Gender differ-
ences were assessed by Student’s t test.
Results: Men had significantly greater LVM (Table) before and after indexation to Ht,
Ht^2.7, BSA and Wt. Indexation to Kuch-FFM eliminated gender differences in LVM,
while Kvist-FFM gave significantly greater adjusted LVM in women.
Conclusion: Men have greater LVM than women and this gender difference persists after
traditional indexation methods. However, indexation to FFM eliminates LVM gender differ-
ences (Kuch) or gives greater indexed LVM in women (Kvist). Further work is needed to
determine the prognostic value of volumetric LVM indexed to FFM.
.
1142-182 Differences in Brain-Natriuretic Peptide and Left 
Ventricular Dimensions and Mass in Normotension, 
Prehypertension and Hypertension
Daniel A. Duprez, Gardar Sigurdsson, Paul Dasari, Natalia Florea, Lynn Hoke, Jay N. 
Cohn, University of Minnesota, Minneapolis, MN
Background: BNP and increase in left ventricular mass (LVM) are associated with
increased cardiovascular risk. The JNC VII guidelines for hypertension considernormo-
tension, prehypertension and hypertension. Surrogate end-markers for cardiovascular
damage in prehypertension are not known.
Objective: To study the significance of BNP and LVM as well as left ventricular enddias-
tolic diameter (LVIDD) in prehypertension versus normotension and hypertension.
Methods:
A total number of 159 subjects with normotension (BP < 120/80 mm Hg); 243 subjects
with prehypertension (BP 120-139/80-89 mm Hg) and 143 subjects with hypertension
(BP > 140/90 mm Hg) underwent an echocardiographic exam and a blood sampling for
BNP.
Results: Data are expressed as mean ± s.e.m. in Table 1. Statistical significance between
prehypertension and normotension and hypertension between prehypertension and nor-
motension has been calculated.
*P < 0.05; ** P < 0.01
Conclusions:
Prehypertension is characterized by a significantly higher LVIDD and LVM in comparison
with normotension and a lower LVIDD and LVM in comparison with hypertension. BNP is
not elevated in prehypertension, but is in hypertensive subjects. Thus prehypertension is
characterized by structural changes in the left ventricle not detectable by increases in
BNP.
2-way ANCOVA adjusting for age, sex and race
Normotensive Hypertensive
PFD (n=71) CFD (n=87) PFD (n=189) CFD (n=205)
BMI (kg/m2) 27 28 27 28*
Fat-free mass (kg) 49 52 48 51*
Adipose mass (kg) 26 32 26 31*
A/FFMr 0.59 0.67 0.60 0.68*
Cardiac output (l/min) 4.73 4.98 4.75 5.12*
Peripheral resistance 1638 1630 1779 1694#
Mean BP (mmHg) 94 98 103 104#
*effect of fat distribution; #effect of hypertension: 0.04<p<0.0001
NAA Women
(n=44)
NAA Men
(n=35)
AA Women
(n=22)
AA Men
(n=6)
Age (yrs) 48±9 48±13 53±14 52±13
LV Ejection
Fraction (%)
66±5 66±6 67±6 65±4
Systolic BP
(mmHg)
121±18 125±18 128±18 131±13
History of
Hypertension (%)
32 49 59 33
LVM/Ht2.7
(g/m2.7)
39±10 45±11 45±11 33±10
Frequency
C Allele
.18 .26 .52 .50
LVM by Gender (mean±SD)
Index None Ht Ht^2.7 BSA Wt Kvist Kuch
Men 156±29 88±16 33±6.5 76±14 1.8±0.36 2.42±0.43 2.55±0.46
Women 110±20 62±14 30±6.4 63±10 1.6±0.29 2.68±0.51 2.51±0.44
p-value <0.001 <0.001 <0.001 <0.001 <0.005 <0.005 0.45, *NS
